Rock Springs Capital Management LP

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1595725 Baltimore, MD

Back to TEVA Full portfolio

Position in TEVA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,370,460

-$49,595 QoQ

Shares Held

45,500

0.0% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Rock Springs Capital Management LP holds $43,551,047 across 7 Drug Manufacturers - Specialty & Generic names. TEVA ranks #6 (3.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	150,450	$19,820,283
2	AMLX	Amylyx Pharmaceuticals, Inc.	499,764	$6,946,719
3	ALKS	Alkermes plc.	183,986	$6,505,744
4	INDV	Indivior Pharmaceuticals, Inc.	200,000	$6,096,000
5	TLPH	Talphera, Inc.	3,589,186	$2,691,889
6	TEVA	Teva Pharmaceutical Industries Ltd This page	45,500	$1,370,460
7	BCRX	Biocryst Pharmaceuticals Inc	12,600	$119,952

All Filings in TEVA

Export CSV

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,370,460	45,500	0.0%	Shares	Sole	2026-05-15
2025-12-31	$1,420,055	45,500	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.